1429439-25-7 Usage
Description
5-chloro-1-ethyl-3-(hydroxymethyl)-6,7-bis((4-methoxybenzyl)oxy)quinolin-4(1H)-one is a synthetic chemical compound characterized by a quinoline core with a chlorine atom and an ethyl group. It features a hydroxymethyl group and is adorned with two (4-methoxybenzyl)oxy groups attached to the quinoline ring. This complex molecular structure may endow it with unique properties and potential biological activities, suggesting its utility in pharmaceutical and material science research.
Uses
Used in Pharmaceutical Research:
5-chloro-1-ethyl-3-(hydroxymethyl)-6,7-bis((4-methoxybenzyl)oxy)quinolin-4(1H)-one is used as a candidate molecule for pharmaceutical research due to its unique structure and potential biological activities. Its complex molecular composition may offer novel therapeutic avenues, although further studies are required to explore its pharmacological properties and efficacy.
Used in Material Science Research:
In the field of material science, 5-chloro-1-ethyl-3-(hydroxymethyl)-6,7-bis((4-methoxybenzyl)oxy)quinolin-4(1H)-one is utilized as a subject of study for its potential to contribute to the development of new materials. Its specific molecular features could influence material properties, such as reactivity, stability, or interaction with other molecules, making it a valuable component in the creation of advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1429439-25-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,9,4,3 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1429439-25:
(9*1)+(8*4)+(7*2)+(6*9)+(5*4)+(4*3)+(3*9)+(2*2)+(1*5)=177
177 % 10 = 7
So 1429439-25-7 is a valid CAS Registry Number.
1429439-25-7Relevant articles and documents
ANTIBACTERIAL COMPOUNDS
-
Page/Page column 134, (2013/04/24)
The present Invention relates to cephalosporin antibacterial compounds of Formula (!): corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods for bacterial infections, especially those caused by gram-negative bacteria.
